| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serum Response Factor | 13 | 2022 | 51 | 2.600 |
Why?
|
| Myocytes, Cardiac | 12 | 2022 | 764 | 1.680 |
Why?
|
| Muscular Atrophy | 3 | 2021 | 105 | 1.360 |
Why?
|
| Myocardium | 19 | 2021 | 1313 | 1.320 |
Why?
|
| Cell Differentiation | 21 | 2022 | 4078 | 1.190 |
Why?
|
| Transcription Factors | 20 | 2019 | 5270 | 1.140 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2019 | 622 | 1.110 |
Why?
|
| Heart | 11 | 2021 | 1223 | 1.090 |
Why?
|
| Muscle, Skeletal | 11 | 2021 | 1270 | 0.950 |
Why?
|
| Transcriptional Activation | 8 | 2019 | 1070 | 0.940 |
Why?
|
| Stem Cells | 9 | 2021 | 1213 | 0.920 |
Why?
|
| Muscle Proteins | 6 | 2016 | 549 | 0.880 |
Why?
|
| Embryoid Bodies | 1 | 2022 | 12 | 0.880 |
Why?
|
| rho-Associated Kinases | 3 | 2019 | 85 | 0.860 |
Why?
|
| Myoblasts | 4 | 2019 | 72 | 0.860 |
Why?
|
| Myocardial Infarction | 5 | 2016 | 1374 | 0.860 |
Why?
|
| Gene Expression Regulation | 14 | 2019 | 4053 | 0.760 |
Why?
|
| Sinoatrial Node | 1 | 2020 | 22 | 0.730 |
Why?
|
| Homeodomain Proteins | 8 | 2014 | 1143 | 0.690 |
Why?
|
| Insulin-Like Growth Factor I | 4 | 2019 | 630 | 0.680 |
Why?
|
| Muscle Development | 5 | 2016 | 88 | 0.650 |
Why?
|
| Myofibrils | 2 | 2016 | 31 | 0.630 |
Why?
|
| Gene Expression Regulation, Developmental | 10 | 2018 | 1498 | 0.610 |
Why?
|
| Coronary Angiography | 4 | 2012 | 598 | 0.610 |
Why?
|
| Pacemaker, Artificial | 1 | 2020 | 213 | 0.600 |
Why?
|
| MicroRNAs | 6 | 2022 | 2947 | 0.570 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 323 | 0.560 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2007 | 125 | 0.550 |
Why?
|
| DNA-Binding Proteins | 7 | 2016 | 4821 | 0.540 |
Why?
|
| Actins | 10 | 2007 | 608 | 0.530 |
Why?
|
| Transcription, Genetic | 7 | 2005 | 3154 | 0.520 |
Why?
|
| Stem Cell Transplantation | 2 | 2016 | 1360 | 0.520 |
Why?
|
| Animals | 60 | 2021 | 59536 | 0.520 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2014 | 71 | 0.500 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2005 | 330 | 0.490 |
Why?
|
| Coronary Stenosis | 4 | 2012 | 117 | 0.490 |
Why?
|
| Mice | 41 | 2021 | 34495 | 0.480 |
Why?
|
| Mesoderm | 8 | 2018 | 404 | 0.480 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2014 | 136 | 0.480 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2005 | 467 | 0.480 |
Why?
|
| Cell Nucleus | 4 | 2016 | 1620 | 0.470 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 2 | 2004 | 21 | 0.460 |
Why?
|
| Peptides | 1 | 2019 | 1479 | 0.450 |
Why?
|
| Fibroblasts | 3 | 2016 | 1682 | 0.440 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2012 | 38 | 0.420 |
Why?
|
| Electrocardiography | 4 | 2018 | 1145 | 0.410 |
Why?
|
| Sumoylation | 1 | 2012 | 84 | 0.400 |
Why?
|
| Muscle, Smooth | 3 | 2006 | 236 | 0.390 |
Why?
|
| Cell Line | 9 | 2022 | 5114 | 0.390 |
Why?
|
| Foundations | 1 | 2010 | 26 | 0.370 |
Why?
|
| Coronary Circulation | 3 | 2012 | 253 | 0.370 |
Why?
|
| Cells, Cultured | 11 | 2019 | 5637 | 0.370 |
Why?
|
| Embryonic Stem Cells | 6 | 2014 | 301 | 0.370 |
Why?
|
| T-Box Domain Proteins | 4 | 2013 | 156 | 0.370 |
Why?
|
| Gravitation | 1 | 2009 | 22 | 0.360 |
Why?
|
| Coronary Disease | 3 | 2010 | 764 | 0.360 |
Why?
|
| Carrier Proteins | 3 | 2018 | 2022 | 0.360 |
Why?
|
| Promoter Regions, Genetic | 11 | 2013 | 3101 | 0.360 |
Why?
|
| Intracranial Embolism | 1 | 2009 | 39 | 0.360 |
Why?
|
| Sarcomeres | 2 | 2008 | 42 | 0.350 |
Why?
|
| Weight-Bearing | 1 | 2009 | 68 | 0.350 |
Why?
|
| GATA4 Transcription Factor | 4 | 2018 | 45 | 0.350 |
Why?
|
| Atrial Appendage | 1 | 2009 | 55 | 0.340 |
Why?
|
| Protein Binding | 10 | 2014 | 3438 | 0.340 |
Why?
|
| Organogenesis | 2 | 2021 | 119 | 0.340 |
Why?
|
| Advisory Committees | 1 | 2010 | 203 | 0.340 |
Why?
|
| Tunica Intima | 3 | 2009 | 117 | 0.330 |
Why?
|
| Wound Healing | 2 | 2020 | 815 | 0.330 |
Why?
|
| Warfarin | 1 | 2009 | 152 | 0.320 |
Why?
|
| Signal Transduction | 15 | 2021 | 11965 | 0.310 |
Why?
|
| Angioplasty, Balloon | 2 | 2008 | 183 | 0.310 |
Why?
|
| Mice, Transgenic | 11 | 2017 | 4143 | 0.310 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2008 | 136 | 0.310 |
Why?
|
| Calcinosis | 3 | 2018 | 423 | 0.310 |
Why?
|
| Physical Endurance | 2 | 2017 | 58 | 0.300 |
Why?
|
| Running | 2 | 2017 | 46 | 0.300 |
Why?
|
| Histone Chaperones | 2 | 2017 | 32 | 0.290 |
Why?
|
| Gonadotropin-Releasing Hormone | 3 | 2018 | 167 | 0.290 |
Why?
|
| Genes, Reporter | 6 | 2016 | 798 | 0.290 |
Why?
|
| Heart Failure | 4 | 2017 | 2516 | 0.280 |
Why?
|
| Mouse Embryonic Stem Cells | 2 | 2016 | 47 | 0.280 |
Why?
|
| Sarcolemma | 2 | 2016 | 32 | 0.280 |
Why?
|
| Myoblasts, Skeletal | 1 | 2006 | 18 | 0.280 |
Why?
|
| Regeneration | 2 | 2016 | 279 | 0.280 |
Why?
|
| Genes, fos | 1 | 2006 | 53 | 0.280 |
Why?
|
| Coronary Artery Disease | 4 | 2017 | 1011 | 0.280 |
Why?
|
| Bone and Bones | 1 | 2009 | 619 | 0.280 |
Why?
|
| Homeobox Protein Nkx-2.5 | 5 | 2005 | 27 | 0.270 |
Why?
|
| Cell Lineage | 5 | 2016 | 668 | 0.270 |
Why?
|
| Gene Silencing | 1 | 2008 | 837 | 0.270 |
Why?
|
| Pluripotent Stem Cells | 1 | 2006 | 123 | 0.270 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2014 | 7551 | 0.260 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2005 | 52 | 0.260 |
Why?
|
| Coronary Restenosis | 1 | 2005 | 63 | 0.260 |
Why?
|
| Drug Implants | 1 | 2004 | 46 | 0.250 |
Why?
|
| SUMO-1 Protein | 1 | 2004 | 22 | 0.250 |
Why?
|
| NIH 3T3 Cells | 3 | 2020 | 260 | 0.250 |
Why?
|
| Catheterization | 1 | 2007 | 410 | 0.250 |
Why?
|
| Embryo, Mammalian | 6 | 2018 | 741 | 0.250 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2004 | 177 | 0.250 |
Why?
|
| Atrioventricular Node | 1 | 2004 | 23 | 0.240 |
Why?
|
| Exercise | 4 | 2018 | 1183 | 0.240 |
Why?
|
| Base Sequence | 7 | 2019 | 4917 | 0.240 |
Why?
|
| Heart Block | 1 | 2004 | 48 | 0.240 |
Why?
|
| Cardiology | 1 | 2010 | 530 | 0.240 |
Why?
|
| Mice, Knockout | 9 | 2018 | 5710 | 0.240 |
Why?
|
| Disease Models, Animal | 7 | 2019 | 7222 | 0.240 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 611 | 0.240 |
Why?
|
| Body Composition | 5 | 2015 | 595 | 0.240 |
Why?
|
| Anticoagulants | 1 | 2009 | 787 | 0.240 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2003 | 8 | 0.240 |
Why?
|
| Estradiol | 2 | 2018 | 748 | 0.230 |
Why?
|
| Avian Proteins | 1 | 2003 | 27 | 0.230 |
Why?
|
| Morphogenesis | 3 | 2021 | 337 | 0.230 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2013 | 107 | 0.220 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2003 | 62 | 0.220 |
Why?
|
| Microcirculation | 1 | 2003 | 200 | 0.220 |
Why?
|
| Bone Density | 4 | 2015 | 476 | 0.220 |
Why?
|
| In Situ Hybridization | 5 | 2005 | 1037 | 0.220 |
Why?
|
| Xenopus Proteins | 1 | 2003 | 185 | 0.210 |
Why?
|
| Nerve Tissue Proteins | 2 | 2021 | 1491 | 0.210 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2004 | 192 | 0.210 |
Why?
|
| Atrial Fibrillation | 1 | 2009 | 719 | 0.210 |
Why?
|
| Models, Animal | 1 | 2004 | 664 | 0.210 |
Why?
|
| Heart Ventricles | 2 | 2005 | 846 | 0.210 |
Why?
|
| Transplantation Chimera | 1 | 2002 | 155 | 0.210 |
Why?
|
| Proteins | 2 | 2014 | 1963 | 0.200 |
Why?
|
| Catheter Ablation | 1 | 2007 | 620 | 0.200 |
Why?
|
| Binding Sites | 5 | 2014 | 2171 | 0.200 |
Why?
|
| Transfection | 7 | 2009 | 2944 | 0.200 |
Why?
|
| Fetal Heart | 1 | 2002 | 105 | 0.200 |
Why?
|
| Aortic Valve Stenosis | 1 | 2007 | 476 | 0.200 |
Why?
|
| Humans | 46 | 2020 | 261506 | 0.200 |
Why?
|
| Trans-Activators | 3 | 2005 | 1555 | 0.200 |
Why?
|
| Stents | 3 | 2004 | 1096 | 0.200 |
Why?
|
| Fractional Flow Reserve, Myocardial | 2 | 2012 | 50 | 0.200 |
Why?
|
| HMGB Proteins | 2 | 2014 | 16 | 0.200 |
Why?
|
| Bone Marrow Transplantation | 1 | 2006 | 1581 | 0.200 |
Why?
|
| HeLa Cells | 3 | 2019 | 1643 | 0.200 |
Why?
|
| Receptor, Notch1 | 2 | 2021 | 218 | 0.190 |
Why?
|
| Cell Proliferation | 7 | 2020 | 7226 | 0.190 |
Why?
|
| Wnt Proteins | 2 | 2013 | 397 | 0.190 |
Why?
|
| Molecular Sequence Data | 7 | 2013 | 6089 | 0.190 |
Why?
|
| RNA, Messenger | 6 | 2019 | 6150 | 0.190 |
Why?
|
| Premenopause | 2 | 2018 | 131 | 0.190 |
Why?
|
| Caspases | 1 | 2003 | 661 | 0.190 |
Why?
|
| Catalytic Domain | 2 | 2019 | 303 | 0.190 |
Why?
|
| Sequence Homology | 1 | 2019 | 71 | 0.180 |
Why?
|
| Silver | 1 | 2020 | 34 | 0.180 |
Why?
|
| Ventricular Function, Left | 1 | 2004 | 603 | 0.180 |
Why?
|
| Biological Clocks | 1 | 2019 | 45 | 0.180 |
Why?
|
| Bandages | 1 | 2020 | 71 | 0.180 |
Why?
|
| Protein Structure, Tertiary | 5 | 2007 | 1487 | 0.170 |
Why?
|
| Resistance Training | 2 | 2018 | 42 | 0.170 |
Why?
|
| Receptors, Androgen | 1 | 2004 | 878 | 0.170 |
Why?
|
| Biomedical Research | 1 | 2006 | 806 | 0.170 |
Why?
|
| Up-Regulation | 3 | 2016 | 2450 | 0.170 |
Why?
|
| Swine | 7 | 2009 | 1541 | 0.170 |
Why?
|
| Keratins | 1 | 2020 | 330 | 0.170 |
Why?
|
| Transgenes | 3 | 2005 | 557 | 0.170 |
Why?
|
| Biocompatible Materials | 1 | 2020 | 202 | 0.170 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2017 | 160 | 0.160 |
Why?
|
| Cardiomyopathies | 2 | 2018 | 610 | 0.160 |
Why?
|
| Endothelial Cells | 3 | 2019 | 1048 | 0.160 |
Why?
|
| Genetic Vectors | 4 | 2005 | 1694 | 0.160 |
Why?
|
| Nuclear Proteins | 2 | 2006 | 3343 | 0.160 |
Why?
|
| Heart Transplantation | 2 | 2003 | 908 | 0.160 |
Why?
|
| Myocardial Ischemia | 2 | 2012 | 435 | 0.160 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2020 | 224 | 0.160 |
Why?
|
| Metal Nanoparticles | 1 | 2020 | 164 | 0.160 |
Why?
|
| Cell Cycle Proteins | 2 | 2017 | 2045 | 0.150 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2018 | 133 | 0.150 |
Why?
|
| Peptide Fragments | 1 | 2003 | 1271 | 0.150 |
Why?
|
| Protein Isoforms | 1 | 2019 | 842 | 0.150 |
Why?
|
| Pericardium | 1 | 2018 | 157 | 0.150 |
Why?
|
| Ovary | 2 | 2018 | 668 | 0.150 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 571 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 6942 | 0.150 |
Why?
|
| Organ Size | 2 | 2016 | 690 | 0.150 |
Why?
|
| Mice, SCID | 3 | 2018 | 1869 | 0.140 |
Why?
|
| Wnt3A Protein | 1 | 2016 | 29 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2016 | 2508 | 0.140 |
Why?
|
| SOXF Transcription Factors | 2 | 2014 | 34 | 0.140 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2016 | 11 | 0.140 |
Why?
|
| Heart, Artificial | 1 | 2017 | 77 | 0.140 |
Why?
|
| LIM Domain Proteins | 3 | 2006 | 104 | 0.140 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2016 | 101 | 0.140 |
Why?
|
| Advance Care Planning | 1 | 2017 | 86 | 0.140 |
Why?
|
| Luciferases | 4 | 2005 | 445 | 0.140 |
Why?
|
| Muscular Diseases | 1 | 2017 | 161 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 461 | 0.140 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2016 | 142 | 0.140 |
Why?
|
| DNA | 4 | 2005 | 2693 | 0.140 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2015 | 36 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 1678 | 0.130 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 717 | 0.130 |
Why?
|
| Leuprolide | 1 | 2015 | 65 | 0.130 |
Why?
|
| Muscle Strength | 1 | 2016 | 104 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2005 | 3639 | 0.130 |
Why?
|
| Lac Operon | 2 | 2005 | 122 | 0.130 |
Why?
|
| beta-Galactosidase | 2 | 2005 | 211 | 0.130 |
Why?
|
| Cardiomegaly | 1 | 2016 | 195 | 0.130 |
Why?
|
| Body Patterning | 4 | 2014 | 212 | 0.130 |
Why?
|
| Dexamethasone | 1 | 2019 | 1450 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2021 | 2819 | 0.120 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2005 | 129 | 0.120 |
Why?
|
| Transcriptome | 3 | 2019 | 1859 | 0.120 |
Why?
|
| Mutation | 8 | 2012 | 15179 | 0.120 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 43 | 0.120 |
Why?
|
| Asthma | 1 | 2002 | 871 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2017 | 1129 | 0.120 |
Why?
|
| Muscles | 2 | 2005 | 416 | 0.120 |
Why?
|
| Hypertension | 2 | 2019 | 1503 | 0.120 |
Why?
|
| rho-Specific Guanine Nucleotide Dissociation Inhibitors | 2 | 2004 | 14 | 0.120 |
Why?
|
| Transcription Factor AP-2 | 1 | 2013 | 79 | 0.120 |
Why?
|
| TCF Transcription Factors | 1 | 2013 | 35 | 0.120 |
Why?
|
| rho Guanine Nucleotide Dissociation Inhibitor alpha | 2 | 2004 | 19 | 0.120 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2013 | 22 | 0.120 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2013 | 37 | 0.110 |
Why?
|
| Zinc Fingers | 2 | 2004 | 205 | 0.110 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2005 | 268 | 0.110 |
Why?
|
| Molecular Docking Simulation | 1 | 2013 | 144 | 0.110 |
Why?
|
| Coronary Vessels | 3 | 2009 | 665 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2014 | 92 | 0.110 |
Why?
|
| Glutathione Transferase | 2 | 2004 | 359 | 0.110 |
Why?
|
| Anovulation | 1 | 2012 | 5 | 0.110 |
Why?
|
| Proteostasis Deficiencies | 1 | 2012 | 8 | 0.110 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2003 | 253 | 0.110 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2014 | 210 | 0.110 |
Why?
|
| Phosphorylation | 2 | 2019 | 4804 | 0.110 |
Why?
|
| Male | 15 | 2021 | 123000 | 0.110 |
Why?
|
| Receptors, LHRH | 1 | 2012 | 41 | 0.110 |
Why?
|
| Biomarkers | 4 | 2014 | 5047 | 0.110 |
Why?
|
| Heart Atria | 2 | 2005 | 352 | 0.110 |
Why?
|
| Postmenopause | 1 | 2014 | 378 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2012 | 32 | 0.100 |
Why?
|
| Cleft Palate | 1 | 2013 | 128 | 0.100 |
Why?
|
| Connexins | 2 | 2019 | 78 | 0.100 |
Why?
|
| Cleft Lip | 1 | 2013 | 127 | 0.100 |
Why?
|
| Amino Acid Sequence | 3 | 2013 | 4233 | 0.100 |
Why?
|
| Cattle | 2 | 2004 | 783 | 0.100 |
Why?
|
| Heterozygote | 2 | 2005 | 1020 | 0.100 |
Why?
|
| Cell Division | 4 | 2004 | 2489 | 0.100 |
Why?
|
| Stomach | 2 | 2005 | 387 | 0.100 |
Why?
|
| Amino Acid Substitution | 3 | 2012 | 644 | 0.100 |
Why?
|
| Research Design | 2 | 2011 | 1544 | 0.100 |
Why?
|
| Cellular Reprogramming | 1 | 2013 | 189 | 0.100 |
Why?
|
| Time Factors | 5 | 2017 | 12926 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2359 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2018 | 1664 | 0.090 |
Why?
|
| Organ Specificity | 2 | 2016 | 699 | 0.090 |
Why?
|
| Female | 18 | 2021 | 141928 | 0.090 |
Why?
|
| Arteritis | 1 | 2009 | 10 | 0.090 |
Why?
|
| Plasmids | 4 | 2004 | 837 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2005 | 2074 | 0.090 |
Why?
|
| Cell Movement | 5 | 2020 | 2466 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2015 | 992 | 0.090 |
Why?
|
| Reference Values | 2 | 2012 | 1099 | 0.090 |
Why?
|
| Hypogonadism | 1 | 2012 | 257 | 0.090 |
Why?
|
| GATA6 Transcription Factor | 1 | 2008 | 23 | 0.080 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2009 | 88 | 0.080 |
Why?
|
| Chromatin | 2 | 2005 | 942 | 0.080 |
Why?
|
| Extracellular Space | 1 | 2008 | 132 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2005 | 3536 | 0.080 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2021 | 116 | 0.080 |
Why?
|
| Cell Transdifferentiation | 1 | 2009 | 112 | 0.080 |
Why?
|
| Testis | 1 | 2012 | 717 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2014 | 731 | 0.080 |
Why?
|
| Drug-Eluting Stents | 1 | 2009 | 131 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2017 | 2063 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2005 | 7548 | 0.080 |
Why?
|
| Aged | 8 | 2017 | 70117 | 0.080 |
Why?
|
| Apoptosis | 4 | 2016 | 7591 | 0.080 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2009 | 197 | 0.080 |
Why?
|
| Recurrence | 2 | 2007 | 4758 | 0.080 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 295 | 0.080 |
Why?
|
| Models, Biological | 5 | 2014 | 3254 | 0.080 |
Why?
|
| Osteoporosis | 1 | 2009 | 241 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 14551 | 0.070 |
Why?
|
| Fractures, Bone | 1 | 2009 | 291 | 0.070 |
Why?
|
| Embryo Research | 1 | 2006 | 10 | 0.070 |
Why?
|
| Registries | 1 | 2014 | 2170 | 0.070 |
Why?
|
| Genome | 2 | 2014 | 672 | 0.070 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 5159 | 0.070 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2006 | 19 | 0.070 |
Why?
|
| Tomography, Spiral Computed | 1 | 2007 | 133 | 0.070 |
Why?
|
| Cadaver | 1 | 2007 | 237 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2009 | 709 | 0.070 |
Why?
|
| Protein Kinase C-alpha | 1 | 2006 | 66 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2006 | 323 | 0.070 |
Why?
|
| Aspartic Acid | 1 | 2006 | 126 | 0.070 |
Why?
|
| Politics | 1 | 2006 | 74 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2008 | 577 | 0.070 |
Why?
|
| Rats | 3 | 2017 | 6086 | 0.070 |
Why?
|
| Computed Tomography Angiography | 2 | 2017 | 234 | 0.070 |
Why?
|
| Tongue | 1 | 2005 | 77 | 0.070 |
Why?
|
| Fetal Death | 2 | 2004 | 113 | 0.070 |
Why?
|
| Calcium | 1 | 2012 | 1537 | 0.070 |
Why?
|
| Muscle Contraction | 1 | 2006 | 218 | 0.070 |
Why?
|
| Paclitaxel | 2 | 2009 | 1996 | 0.070 |
Why?
|
| 5' Flanking Region | 1 | 2004 | 21 | 0.060 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2004 | 26 | 0.060 |
Why?
|
| Rupture, Spontaneous | 1 | 2004 | 70 | 0.060 |
Why?
|
| Sirolimus | 1 | 2009 | 814 | 0.060 |
Why?
|
| Ligands | 2 | 2004 | 995 | 0.060 |
Why?
|
| Databases as Topic | 1 | 2005 | 133 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 448 | 0.060 |
Why?
|
| Middle Aged | 8 | 2018 | 86204 | 0.060 |
Why?
|
| Angina Pectoris | 1 | 2004 | 80 | 0.060 |
Why?
|
| Serine | 1 | 2006 | 388 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 568 | 0.060 |
Why?
|
| Connexin 43 | 1 | 2004 | 46 | 0.060 |
Why?
|
| Autopsy | 1 | 2004 | 173 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2005 | 161 | 0.060 |
Why?
|
| Sus scrofa | 1 | 2004 | 169 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 418 | 0.060 |
Why?
|
| Acetyltransferases | 1 | 2004 | 143 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 392 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2007 | 8865 | 0.060 |
Why?
|
| Disease Progression | 3 | 2004 | 6682 | 0.060 |
Why?
|
| Heart Rate | 2 | 2017 | 737 | 0.060 |
Why?
|
| Smad1 Protein | 1 | 2003 | 35 | 0.060 |
Why?
|
| Actinin | 1 | 2003 | 21 | 0.060 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2003 | 12 | 0.060 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2004 | 54 | 0.060 |
Why?
|
| Linear Models | 1 | 2007 | 1085 | 0.060 |
Why?
|
| Receptors, Steroid | 1 | 2005 | 286 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2003 | 329 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2003 | 189 | 0.060 |
Why?
|
| Myosin Heavy Chains | 1 | 2004 | 128 | 0.060 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2005 | 314 | 0.060 |
Why?
|
| Single-Blind Method | 1 | 2004 | 409 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 518 | 0.060 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 343 | 0.060 |
Why?
|
| Kinetics | 3 | 2020 | 2049 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 591 | 0.060 |
Why?
|
| Constriction, Pathologic | 1 | 2004 | 310 | 0.060 |
Why?
|
| F-Box Proteins | 1 | 2004 | 96 | 0.060 |
Why?
|
| Smad Proteins | 1 | 2003 | 88 | 0.060 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 2003 | 13 | 0.060 |
Why?
|
| Dobutamine | 1 | 2003 | 54 | 0.060 |
Why?
|
| Species Specificity | 1 | 2004 | 777 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2005 | 6869 | 0.060 |
Why?
|
| Rabbits | 1 | 2004 | 957 | 0.060 |
Why?
|
| Hyperplasia | 1 | 2004 | 557 | 0.060 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2005 | 287 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 185 | 0.060 |
Why?
|
| Elastin | 1 | 2003 | 49 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 191 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2006 | 1258 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 411 | 0.050 |
Why?
|
| Models, Genetic | 2 | 2004 | 1113 | 0.050 |
Why?
|
| Chick Embryo | 1 | 2003 | 242 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 1213 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2004 | 299 | 0.050 |
Why?
|
| Smad4 Protein | 1 | 2003 | 196 | 0.050 |
Why?
|
| Body Weight | 2 | 2017 | 1293 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 293 | 0.050 |
Why?
|
| RNA | 2 | 2005 | 1013 | 0.050 |
Why?
|
| Protein Transport | 1 | 2004 | 734 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 769 | 0.050 |
Why?
|
| DNA Primers | 1 | 2004 | 1399 | 0.050 |
Why?
|
| Gadolinium | 1 | 2003 | 164 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2014 | 12873 | 0.050 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 2002 | 13 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2004 | 383 | 0.050 |
Why?
|
| Lysine | 1 | 2004 | 422 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2003 | 471 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2004 | 360 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5319 | 0.050 |
Why?
|
| Weight Gain | 2 | 2003 | 464 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2004 | 1442 | 0.050 |
Why?
|
| Peptide Initiation Factors | 1 | 2021 | 45 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 925 | 0.050 |
Why?
|
| Cyclin E | 1 | 2004 | 267 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2003 | 217 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 2927 | 0.050 |
Why?
|
| Mifepristone | 1 | 2002 | 147 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2007 | 2231 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 4971 | 0.050 |
Why?
|
| Risk Factors | 3 | 2017 | 17523 | 0.050 |
Why?
|
| Gene Expression | 2 | 2017 | 3570 | 0.050 |
Why?
|
| Disease Management | 1 | 2007 | 1052 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2003 | 244 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2017 | 1467 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2018 | 2588 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2003 | 145 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2003 | 829 | 0.050 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2007 | 563 | 0.050 |
Why?
|
| United States | 2 | 2010 | 15433 | 0.050 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2001 | 154 | 0.050 |
Why?
|
| Equipment Design | 1 | 2004 | 1204 | 0.050 |
Why?
|
| Adult | 7 | 2018 | 77950 | 0.050 |
Why?
|
| Stroke | 1 | 2009 | 1144 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2004 | 444 | 0.050 |
Why?
|
| Adenosine | 1 | 2003 | 289 | 0.050 |
Why?
|
| Th2 Cells | 1 | 2002 | 257 | 0.050 |
Why?
|
| Spleen | 1 | 2003 | 676 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2002 | 250 | 0.050 |
Why?
|
| Radiography | 1 | 2005 | 1904 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 891 | 0.050 |
Why?
|
| Hypercholesterolemia | 1 | 2003 | 259 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2003 | 246 | 0.050 |
Why?
|
| Integrases | 2 | 2016 | 262 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2007 | 2803 | 0.050 |
Why?
|
| Colloids | 1 | 2020 | 34 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 803 | 0.050 |
Why?
|
| Luminescent Proteins | 2 | 2016 | 289 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2003 | 1764 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 75 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2002 | 269 | 0.040 |
Why?
|
| Gastric Mucosa | 1 | 2003 | 613 | 0.040 |
Why?
|
| Endocardial Cushions | 1 | 2018 | 4 | 0.040 |
Why?
|
| Light | 1 | 2020 | 245 | 0.040 |
Why?
|
| Prevalence | 1 | 2007 | 3260 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2007 | 935 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 716 | 0.040 |
Why?
|
| Endocardium | 1 | 2018 | 50 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 53 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2002 | 621 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2004 | 2216 | 0.040 |
Why?
|
| Cytokines | 2 | 2020 | 2809 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2002 | 1144 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 521 | 0.040 |
Why?
|
| Bioreactors | 1 | 2017 | 49 | 0.040 |
Why?
|
| Genetic Therapy | 2 | 2002 | 1616 | 0.040 |
Why?
|
| Group Processes | 1 | 2017 | 53 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 733 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2017 | 162 | 0.040 |
Why?
|
| Remission Induction | 1 | 2003 | 3569 | 0.040 |
Why?
|
| Models, Cardiovascular | 2 | 2011 | 202 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 11538 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2008 | 1697 | 0.040 |
Why?
|
| Alleles | 2 | 2018 | 2437 | 0.040 |
Why?
|
| Body Height | 1 | 2017 | 231 | 0.040 |
Why?
|
| CELF1 Protein | 1 | 2016 | 46 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 994 | 0.040 |
Why?
|
| Hippocampus | 1 | 2002 | 915 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2016 | 73 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 1439 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2001 | 1130 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2017 | 426 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2016 | 208 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2017 | 291 | 0.030 |
Why?
|
| Fibrosis | 2 | 2009 | 793 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2020 | 548 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2017 | 341 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 1489 | 0.030 |
Why?
|
| Nodal Protein | 1 | 2014 | 21 | 0.030 |
Why?
|
| Inhibin-beta Subunits | 1 | 2014 | 21 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 237 | 0.030 |
Why?
|
| Triglycerides | 1 | 2017 | 603 | 0.030 |
Why?
|
| Glucose Clamp Technique | 1 | 2014 | 89 | 0.030 |
Why?
|
| Phenotype | 3 | 2018 | 6295 | 0.030 |
Why?
|
| Skin | 1 | 2020 | 1259 | 0.030 |
Why?
|
| Heart-Assist Devices | 1 | 2003 | 1171 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 644 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 85 | 0.030 |
Why?
|
| Lipolysis | 1 | 2014 | 108 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2013 | 105 | 0.030 |
Why?
|
| RNA Interference | 2 | 2009 | 1408 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2020 | 1203 | 0.030 |
Why?
|
| Cell Survival | 1 | 2020 | 3045 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2014 | 239 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 1271 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 29902 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2013 | 336 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2013 | 220 | 0.030 |
Why?
|
| Luteinization | 1 | 2012 | 13 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 973 | 0.030 |
Why?
|
| Estrous Cycle | 1 | 2012 | 37 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2013 | 123 | 0.030 |
Why?
|
| Echocardiography | 1 | 2018 | 1182 | 0.030 |
Why?
|
| Gonadotropins | 1 | 2012 | 50 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 492 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 280 | 0.030 |
Why?
|
| Fetus | 1 | 2016 | 601 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2013 | 469 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2011 | 70 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 634 | 0.020 |
Why?
|
| North America | 1 | 2011 | 314 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 1029 | 0.020 |
Why?
|
| Point Mutation | 1 | 2013 | 769 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 717 | 0.020 |
Why?
|
| Overweight | 1 | 2014 | 484 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 2315 | 0.020 |
Why?
|
| Inflammation | 1 | 2020 | 2522 | 0.020 |
Why?
|
| Europe | 1 | 2011 | 649 | 0.020 |
Why?
|
| Leukocyte Rolling | 1 | 2009 | 18 | 0.020 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2009 | 19 | 0.020 |
Why?
|
| Fibrin | 1 | 2009 | 82 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2014 | 37905 | 0.020 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2011 | 361 | 0.020 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2008 | 68 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2009 | 203 | 0.020 |
Why?
|
| Eosinophils | 1 | 2009 | 162 | 0.020 |
Why?
|
| DNA Repair | 1 | 2016 | 1872 | 0.020 |
Why?
|
| Insulin | 1 | 2014 | 1454 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 1954 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 4938 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2014 | 1863 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2992 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 7702 | 0.020 |
Why?
|
| Lentivirus | 1 | 2007 | 169 | 0.020 |
Why?
|
| Adolescent | 1 | 2007 | 31252 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 2203 | 0.020 |
Why?
|
| Cerebral Revascularization | 1 | 2005 | 23 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 6009 | 0.020 |
Why?
|
| Embryonic Induction | 1 | 2005 | 54 | 0.020 |
Why?
|
| COUP Transcription Factors | 1 | 2005 | 50 | 0.020 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2004 | 26 | 0.020 |
Why?
|
| COUP Transcription Factor II | 1 | 2005 | 126 | 0.020 |
Why?
|
| Receptor, Notch4 | 1 | 2004 | 13 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 139 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2008 | 852 | 0.010 |
Why?
|
| Dystrophin | 1 | 2003 | 41 | 0.010 |
Why?
|
| DiGeorge Syndrome | 1 | 2004 | 77 | 0.010 |
Why?
|
| Myotonin-Protein Kinase | 1 | 2003 | 36 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2004 | 234 | 0.010 |
Why?
|
| Vinculin | 1 | 2003 | 18 | 0.010 |
Why?
|
| Thrombophilia | 1 | 2003 | 56 | 0.010 |
Why?
|
| Threonine | 1 | 2003 | 161 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 377 | 0.010 |
Why?
|
| Autocrine Communication | 1 | 2003 | 84 | 0.010 |
Why?
|
| Vitamin A | 1 | 2003 | 94 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2003 | 114 | 0.010 |
Why?
|
| Vitamin E | 1 | 2003 | 136 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 2004 | 257 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2004 | 292 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2003 | 79 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 4892 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 2005 | 424 | 0.010 |
Why?
|
| Tubulin | 1 | 2003 | 169 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 869 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2003 | 276 | 0.010 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2003 | 198 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2003 | 358 | 0.010 |
Why?
|
| Protein Engineering | 1 | 2002 | 100 | 0.010 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2003 | 347 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 2003 | 321 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2003 | 396 | 0.010 |
Why?
|
| Chickens | 1 | 2002 | 523 | 0.010 |
Why?
|
| Obesity | 1 | 2014 | 2884 | 0.010 |
Why?
|
| Injections | 1 | 2002 | 285 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2003 | 414 | 0.010 |
Why?
|
| Telomerase | 1 | 2004 | 525 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 538 | 0.010 |
Why?
|
| Prognosis | 2 | 2011 | 21713 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2004 | 383 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2001 | 267 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 2594 | 0.010 |
Why?
|
| Syndrome | 1 | 2003 | 1351 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 862 | 0.010 |
Why?
|
| Antibodies | 1 | 2003 | 838 | 0.010 |
Why?
|
| Antioxidants | 1 | 2003 | 507 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2005 | 1271 | 0.010 |
Why?
|
| Placenta | 1 | 2004 | 516 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 694 | 0.010 |
Why?
|
| Consensus | 1 | 2003 | 978 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2003 | 1546 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 2422 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2002 | 1338 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 2283 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 21445 | 0.010 |
Why?
|
| Mass Screening | 1 | 2003 | 1509 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 2488 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 32848 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 4320 | 0.010 |
Why?
|
| Age Factors | 1 | 2002 | 5377 | 0.010 |
Why?
|
| Neurons | 1 | 2002 | 2287 | 0.010 |
Why?
|
| Pregnancy | 1 | 2004 | 7573 | 0.010 |
Why?
|